# A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health

> **NCT05808049** · NA · COMPLETED · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **OTHER:** MXP22 (Probiotic and antioxidant capsule)
- **OTHER:** Placebo (Microcrystalline Cellulose)

## Key facts

- **NCT ID:** NCT05808049
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-06
- **Primary completion:** 2023-07-04
- **Final completion:** 2023-07-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808049, "A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05808049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*